| |
|
What We Are Offering?
The Jasos® Group provides increased product
access within the US and Puerto Rico through:
|
 | | |
| |
For Clients with specialty pharmaceuticals (ophthalmics, oncology, infectious disease, cardiovascular, allergy, urology, 510K specialty products, diabetes, and biologicals), and those with a broader portfolio of products.
|
|
|
 
|
|
|
|
|
|
The Jasos® Group
We are a clinically-based pharmacy consulting firm that works with Pharmaceutical Manufacturers to provide back-office and front-line support to increase State, Federal, and Commercial product access and reimbursement.
|
|
|
|
|
| |
Why Government Markets?
 |
VA/DoD:
Access a market bigger than Kaiser, HealthNet, and Coventry combined and more than 10% of all managed care lives with 16 million beneficiaries and $11.4 billion drug spend in 2006. Source AIS
|
|
Medicaid:
With 45.4 million lives, this market represents 18% of all insured lives and a $24 billion drug spend in 2006. Source CMS
|
|
|
 |
|
|
|
| |
Latest Updates:
|
IL |
SB 773 |
Drug Prices |
Passed Committe |
|
CA |
AB 378 |
PhRMA Reporting of Gifts and Mktg |
Passed Chamber |
|
ME |
LD 719 |
Clinical Trials |
Approved |
StateScape Session Updates
|
OR: Regular Session Convenes
|
31 Jan 2012
|
|
MN: Regular Session Reconvenes
|
23 Jan 2012
|
|
HI: Regular Session Convenes
|
18 Jan 2012
|
|
NM: Regular Session Convenes
|
17 Jan 2012
|
|
VA: 2012 Session Convenes
|
11 Jan 2012
|
|
|
|
|
